Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours

Completed · Phase 3 · Has a placebo group

Conditions studied: Endocrine Tumors

In brief

The study will compare the difference between lanreotide Autogel and placebo on progression free survival in patients who have an endocrine tumour in the pancreas or intestines.

Key facts

Study ID

NCT00353496

Run by

Ipsen

People needed

264

Starts

2006-06-01

Expected to finish

2013-04-01

Last updated by the study team

2025-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Endocrine tumour in the intestine or pancreas and with locally advanced or metastatic disease
• No hormone related symptoms
• Well or moderately differentiated tumour confirmed by histology
• Tumour lesions which are measurable by a CT or MRI scan

You may not qualify if…

• Previously treated with a somatostatin analogue unless more than 6 months ago and given for no more than 15 days
• Treated within the last 6 months with interferon, chemoembolisation or chemotherapy or at any time with a radionuclide
• Had a previous cancer except basal cell carcinoma and/or in situ carcinoma of the cervix/uterus and/or patients treated with curative intent and free from disease for 5 years
• Pregnant or lactating
• Females must use adequate contraception during the study

Where it is running

• University of Iowa — Iowa City, Iowa, United States
• The John Hopkins Hospital — Baltimore, Maryland, United States
• Dana Farber Cancer Institute — Boston, Massachusetts, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• Providence Portland Medical Center — Portland, Oregon, United States
• MD Anderson Cancer Center — Houston, Texas, United States
• University of Wisconsin School of Medicine and Public Health — Madison, Wisconsin, United States
• University Hospital — Vienna, Austria
• UZ Antwerpen — Antwerp, Belgium
• UCL Saint Luc — Brussels, Belgium
• UZ Gent — Ghent, Belgium
• Fakultni nemocnice Na — Bulovce, Prague, Czechia
• Fekultni nemocnice Olomouc — Olomouc, Czechia
• General faculty — Prague, Czechia
• Sygehus Hospital — Aarhus, Denmark
• Rigshospitalet — Copenhagen, Denmark
• Hôpital A. Paré — Boulogne-Billancourt, France
• Hôpital Beaujon — Clichy, France
• CAC Oscar Lambret — Lille, France
• Hôpital Edouard Herriot — Lyon, France
• CHU la Timone — Marseille, France
• Hôpital R. Debré — Reims, France
• CHI Frejus St Raphael — Saint-Raphaël, France
• Hôpital Rangueil — Toulouse, France
• Cedars-Sinai Outpatient Cancer Center — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.